首页> 外文期刊>Expert opinion on drug delivery >Liquisolid technique: A promising alternative to conventional coating for improvement of drug photostability in solid dosage forms
【24h】

Liquisolid technique: A promising alternative to conventional coating for improvement of drug photostability in solid dosage forms

机译:液固技术:一种改善固体剂型中药物光稳定性的传统涂层的有前途的替代方法

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: The objective of this study was to investigate the photoprotective effect of liquisolid technique on amlodipine, a calcium channel blocker antihypertensive drug, representing a photosensitive drug model. Method: Several liquisolid formulations were prepared using propylene glycol as a water-miscible nonvolatile vehicle at drug/solvent ratio (1:1), Avicel PH 102 as a carrier, nanometer-sized amorphous silicon and titanium dioxide either alone or in combination as coating materials. The carrier/coat ratio (R) was varied from 5 to 50. The prepared liquisolids, coated, noncoated tablets and drug substance were irradiated with a light dose of 0.5 W/m2/h visible light, 55.1 W/m2/h UVA, and 0.247 W/m2/h UVB for 8 h. The effect of coating material type and (R) value on the drug dissolution rate and photostability was studied. Results were statistically analyzed by post hoc two-way ANOVA at a probability level (α = 0.05). Results: The results indicated that liquisolid technique not only improved the dissolution rate, but also significantly inhibited the photodegradative effect of different light energies in all prepared liquisolid formulations. The residual drug percentage reached 97.37% in comparison to 73.8% for the drug substance after 8 h of irradiation. The residual drug percentage was affected by the (R) value. Statistically; the detected difference was significant at the selected probability level (α = 0.05). Conclusion: It can thus be concluded that this liquisolid technique is a promising alternative to conventional coating procedures in formulations containing photosensitive drugs.
机译:目的:本研究的目的是研究液固技术对氨氯地平(一种代表光敏药物模型的钙通道阻滞剂降压药)的光保护作用。方法:使用丙二醇作为药物/溶剂比(1:1),与水混溶的非挥发性载体,Avicel PH 102作为载体,纳米级非晶硅和二氧化钛(单独或组合使用)制备几种液体固体制剂材料。载体/包衣比(R)在5到50之间变化。用0.5 W / m2 / h可见光,55.1 W / m2 / h UVA的光剂量辐照制备的液状固体,包衣的,未包衣的片剂和药物。和0.247 W / m2 / h UVB持续8 h。研究了包衣材料类型和(R)值对药物溶出度和光稳定性的影响。通过事后双向方差分析以概率水平(α= 0.05)对结果进行统计分析。结果:结果表明,液固技术不仅提高了溶解速度,而且还显着抑制了所有制备的液固制剂中不同光能的光降解作用。照射8小时后,残留药物百分比达到97.37%,而原料药的残留百分比为73.8%。残留药物百分比受(R)值的影响。统计上;在选定的概率水平(α= 0.05)下,检测到的差异显着。结论:因此可以得出结论,在含有光敏药物的制剂中,这种液体固体技术是一种有希望的替代常规包衣方法的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号